Research News and Research

RSS

Pfizer, Sanford-Burnham to partner on translational medicine research

Sanford-Burnham Medical Research Institute is the latest research organization to partner with Pfizer, Inc. as part of Pfizer's commitment to transforming research and development through a focus on translational medicine.

4 Nov 2011

The skinny on 'narrow networks'

Health Net of Arizona is joining with Banner Health to offer a new type of HMO plan. In other news, Health News Florida reports on WellCare and Humana's profits.

4 Nov 2011

University of Nebraska to honor UT Dallas director for communication research

The University of Nebraska will honor Dr. Thomas Campbell, executive director of the UT Dallas Callier Center for Communication Disorders, for a long record of research and academic achievement at the university's annual Alumni Masters Week.

4 Nov 2011

Media coverage of potential link between hormonal contraception, HIV risk needed more 'critical thinking'

In a Nature News opinion piece, James Shelton, science adviser for USAID's Bureau for Global Health, discusses media coverage of recent findings from the journal Lancet Infectious Diseases showing that women's use of hormonal contraception (HC) may increase the risk of HIV acquisition or transmission.

4 Nov 2011

Scientists discover alternative mechanism for extension of telomeres

Scientists of the German Cancer Research Center have discovered an alternative mechanism for the extension of the telomere repeat sequence by DNA repair enzymes.

4 Nov 2011

Amphetamine use in adolescence can affect brain chemistry and behaviour

Amphetamine use in adolescence can cause neurobiological imbalances and increase risk-taking behaviour, and these effects can persist into adulthood, even when subjects are drug free. These are the conclusions of a new study using animal models conducted by McGill University Health Centre (MUHC) researcher Dr. Gabriella Gobbi and her colleagues.

4 Nov 2011

Longer looks: A doctor's dilemma on C-sections; apology for a death sparked a hospital's change

I was the obstetrician on hospital duty that Sunday morning, so I introduced myself and learned that the patient, pregnant with her first child, wished to have as few interventions as possible. Respecting her desire, we decided to reevaluate her in a few hours to see how her labor had progressed. But would she get her wish? ... the odds were greater than 1 in 4 that this woman would end up not with the natural delivery she wanted, but with a surgical delivery in one of the two operating rooms down the hall.

4 Nov 2011

TPI announces formulation expansion program for GMOL

Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine (TCM), branded generics and active pharmaceutical ingredients (API) today announced the formulation expansion program for its flagship product Gingko Mihuan Oral Liquid.

4 Nov 2011

Sensor system can monitor heart rate, skin conductance while driving

Safety in traffic depends on a number of factors. One decisive aspect is how fit the driver is. A research team at the Technische Universitaet Muenchen (TUM), in collaboration with researchers at the BMW Group, managed to develop a sensor system integrated into the steering wheel that can monitor the driver's state of health while driving.

4 Nov 2011

Scientists identify mechanism by which GBM promotes neurodegeneration

Researchers from Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine have discovered a mechanism by which glioblastoma multiforme (GBM), the most common form of brain cancer, promotes the loss of function or death of neurons, a process known as neurodegeneration.

4 Nov 2011

Mental health intervention can help prevent suicides among youth

Roughly 1 million people die by suicide each year. In the U.S., where nearly 36,000 people take their own lives annually, more than 4,600 victims are between the ages of 10 and 24, making suicide the third leading cause of death in this age group.

4 Nov 2011

PlusNews reports on importance of cost-effectiveness of ZAMSTAR study for policymakers, donors amid economic downturn

PlusNews reports on the results of the Zambia-South Africa TB and AIDS Reduction (ZAMSTAR) study released on Monday at the International Lung Health Conference in Lille, France, which show that "home-based tuberculosis (TB) education and testing reduced community TB prevalence by about 20 percent."

4 Nov 2011

Scientists discover neurons responsible for light-induced arousal response

Bright light arouses us. Bright light makes it easier to stay awake. Very bright light not only arouses us but is known to have antidepressant effects. Conversely, dark rooms can make us sleepy. It's the reason some people use masks to make sure light doesn't wake them while they sleep.

4 Nov 2011

Escitalopram reduces pain severity, interference in opioid-dependent patients

In what is believed to be the first study of its kind to demonstrate an association between the antidepressant escitalopram and improved general pain, researchers from Boston University School of Medicine (BUSM), have found that opioid-dependent patients treated with escitalopram experienced meaningful reductions in pain severity and pain interference during the first three months of therapy.

4 Nov 2011

Penn research group receives NCI grant to establish BETRNet

A research group at the Perelman School of Medicine of the University of Pennsylvania, led by John Lynch, MD, PhD, assistant professor of Medicine in the Division of Gastroenterology, has received a National Cancer Institute (NCI) grant to establish a Barrett's esophagus translational research network (BETRNet) with Columbia University and the Mayo Clinic.

4 Nov 2011

Scientists identify gene responsible for abdominal aortic aneurysms

Medical scientists have for the first time identified a gene responsible for a fatal abdominal condition that afflicts tens of thousands of people across the world.

4 Nov 2011

Bristol-Myers Squibb, ASLAN partner to develop BMS-777607 for solid tumors

ASLAN Pharmaceuticals Pte Ltd, a pharmaceutical company headquartered in Singapore, and Bristol-Myers Squibb Company today announced an innovative strategic partnership allowing for the rapid development of BMS-777607, Bristol-Myers Squibb's investigational small molecule inhibitor of the MET receptor tyrosine kinase for treatment of solid tumors.

4 Nov 2011

Evolutionary 'breakpoints' on chromosomes may lead to canine cancer

North Carolina State University researchers have uncovered evidence that evolutionary "breakpoints" on canine chromosomes are also associated with canine cancer. Mapping these "fragile" regions in dogs may also have implications for the discovery and treatment of human cancers.

4 Nov 2011

Climate change, environmental destruction threaten improvements among world's poorest, UNDP report warns

"Unchecked environmental destruction will halt -- or even reverse -- the huge improvements seen in the living conditions of the world's poorest people in recent decades," the United Nations Development Programme (UNDP) warns in its 2011 Human Development report, which was released on Wednesday, the Guardian reports.

4 Nov 2011

Merck’s cholesterol lowering drug gets FDA panel’s vote

A health advisors’ panel have unanimously backed the use of Merck & Co's cholesterol-lowering drug Vytorin for preventing stroke and other heart problems in patients with chronic kidney disease, but only in those patients not yet on dialysis. The panel voted 16-0 during a meeting today in Silver Spring, Maryland.

3 Nov 2011